Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rostelecom reported for 9 months of 2024 by IFRS

11/12/24 RTKM

EuroTrans reported for 9 months of 2024 by RAS

11/12/24 EUTR

M.Video-Eldorado's GMV for 9 months grew by 8%

11/12/24 MVID

M.video reported for 9 months of 2024 by RAS

11/11/24 MVID

Abrau-Durso and Indian Minchy's started production of sparkling wine

11/11/24 ABRD

Novabev Group reported for 9 months of 2024 by RAS

11/11/24 BELU

Board of Directors of RPA Nauka recommended dividends

11/11/24 NAUK

Sovcombank reported for 9 months of 2024 by RAS

11/11/24 SVCB

Finuservices has launched an online showcase of NPF's PDS offerings

11/11/24 MOEX

Rusagro reported for 9 months of 2024 by IFRS

11/11/24 AGRO